MegaMD KRX:133750KOSDAQ
메가엠디 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days1
DART filings, 7 days0
Articles tracked1since Sep 11
In Q2 2026, MegaMD reported operating profit of ₩995m. MegaMD (메가엠디) appeared in 1 Korean news article and 0 DART filings over the past seven days. Coverage peaked on Sep 29 with 1 article.
MegaMD quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | – | – | ₩995m | ₩1.6bn |
| Q1 2026 | ₩7.8bn | -7.1% | ₩150m margin 1.9% | ₩1.9bn |
| Q4 2025 derived | ₩7.1bn | +0.2% | −₩570m margin −8.0% | −₩609m |
| Q3 2025 | ₩9.3bn | -6.2% | ₩1.7bn margin 17.9% | ₩2.2bn |
| Q2 2025 | ₩9.8bn | -9.0% | ₩1.2bn margin 12.4% | ₩1.4bn |
| Q1 2025 | ₩8.4bn | -3.8% | −₩492m margin −5.9% | −₩194m |
| Q4 2024 derived | ₩7.1bn | +6.0% | −₩978m margin −13.7% | ₩368m |
| Q3 2024 | ₩9.9bn | +2.6% | ₩1.3bn margin 13.5% | ₩899m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
MegaMD top stories 2 weeks, by number of outlets
- 1